Open Access. Powered by Scholars. Published by Universities.®
Medicinal-Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Synthesis (2)
- Adverse outcome pathway;deep learning;interpretable machine learning;machine learning;mechanistic modeling;QSAR (1)
- Alkaloid derivatives (1)
- Antibody; Glycosylation; HPLC; Peptides; Protein; Separation (1)
- Antimicrobial (1)
-
- Ara h 2 (1)
- Artemisinin; dihydroartemisinin; artesunate; HPLC/TOF-MS (1)
- Aza Heterocyclic Compounds (1)
- Azurin (1)
- Baylis-Hillman (1)
- Beta-amino alcohols (1)
- Bio-Renewable (1)
- Biochemistry; Biophysics; Computer aided drug design; Molecular Dynamics; Molecular mechanics; Protein kinetics (1)
- Brain chemistry (1)
- Cancer;Medicinal Chemistry;Organic Chemistry;Pharmacology;Salinomycin;Salinomycin Derivatives (1)
- Chromatography (1)
- Cocaine (1)
- Color Science (1)
- Cosmetic Chemistry (1)
- Cross-linkers (1)
- Crosslink (1)
- Crystal structure (1)
- Cue-induced cocaine seeking (1)
- Cyanopyrrolidines (1)
- Cyclic voltammetry; electro-polymerization; molecular imprinting; o-phenylenediamine; oxycodone; square wave voltammetry (1)
- DNA (1)
- Density Functional Theory (1)
- Diabetes (1)
- Dipeptidyl Peptidase-IV (1)
- Dopamine receptors (1)
- Publication Year
- Publication
- Publication Type
Articles 31 - 34 of 34
Full-Text Articles in Medicinal-Pharmaceutical Chemistry
Development Of Novel Therapeutic Approaches: (I) Targeting Allergic Responses To Peanuts And (Ii) Inhibition Of Dpp-Iv Enzyme Involved In Diabetes, Savan V. Patel
Theses and Dissertations
There is an increase in prevalence of peanut allergy, especially in the western world. The only current treatment for peanut allergy is avoidance of peanut from diet and contact. Additionally, there is currently no specific vaccine that can be taken to decrease peanut allergies. The method of desensitizing a person allergic to peanut allergy is deemed unsafe as the smallest amount of peanut can trigger an anaphylaxis reaction. Thus, various allergoids were created by modifying major peanut protein allergen Ara h2 using various cross-linkers and modification agents in order to disrupt the binding surface epitopes of the antigen to antibody. …
Cytotoxic And Antimicrobial Effects Of Silver-Containing Surfaces, Sarah Goderecci
Cytotoxic And Antimicrobial Effects Of Silver-Containing Surfaces, Sarah Goderecci
Theses and Dissertations
This study examines applications of sputtered silver coatings as alternatives to traditional antibiotic treatments. Given the increase in reports of antibiotic-resistant bacteria, new treatments and coatings for in-dwelling medical devices such as catheters and orthopedic implants are necessary. Silver oxide films were deposited onto Ti surfaces to examine the efficacy of such coatings against a variety of bacterial species both in vitro and in vivo. Bacterial growth studies showed that coatings exhibited antimicrobial activity against a range of bacterial species acting either in a bacteriostatic or bactericidal mechanism, depending on the target. Limited toxicity to in vitro mammalian cells was …
Identifying Medication Targets For Psychostimulant Addiction: Unraveling The Dopamine D3 Receptor Hypothesis, Thomas M. Keck, William S. John, Paul W. Czoty, Michael A. Nader, Amy Hauck Newman
Identifying Medication Targets For Psychostimulant Addiction: Unraveling The Dopamine D3 Receptor Hypothesis, Thomas M. Keck, William S. John, Paul W. Czoty, Michael A. Nader, Amy Hauck Newman
College of Science & Mathematics Departmental Research
The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in vivo models of drug abuse. D3R antagonists and partial agonists have shown especially promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking. However, to date, translation to human studies has been limited. Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compounds toward clinical …
A Novel Mglur5 Antagonist, Mfz 10-7, Inhibits Cocaine-Taking And Cocaine-Seeking Behavior In Rats, Thomas Keck, Mu-Fa Zou, Gui-Hua Bi, Hai-Ying Zhang, Xiao-Fei Wang, Hong-Ju Yang, Ratika Srivastava, Elliott L. Gardner, Zheng-Xiong Xi, Amy Hauck Newman
A Novel Mglur5 Antagonist, Mfz 10-7, Inhibits Cocaine-Taking And Cocaine-Seeking Behavior In Rats, Thomas Keck, Mu-Fa Zou, Gui-Hua Bi, Hai-Ying Zhang, Xiao-Fei Wang, Hong-Ju Yang, Ratika Srivastava, Elliott L. Gardner, Zheng-Xiong Xi, Amy Hauck Newman
College of Science & Mathematics Departmental Research
Pre-clinical studies suggest that negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR5), including 2-methyl-6-(phenylethynyl)pyridine (MPEP), 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) and fenobam are highly effective in attenuating drug-taking and drug-seeking behaviors. However, both MPEP and MTEP have no translational potential for use in humans because of their off-target effects and short half-lives. Here, we report that 3-fluoro-5-[(6-methylpyridin-2-yl)ethynyl]benzonitrile (MFZ 10-7), a novel mGluR5 NAM, is more potent and selective than MPEP, MTEP and fenobam in both in vitro binding and functional assays. Similar to MTEP, intraperitoneal administration of MFZ 10-7 inhibited intravenous cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and …